Tekumo Inc (TKMO)

[BIOCHEMUP]

PR from 2022 when they planned an expansion phase for 2023, which they succeeded as evidenced by the Q-to-Q growth in ‘23: Q1 ($200K), Q2 ($400K), Q3 ($800K), Q4 ($1.2M-1.4M)

In summary, we have accomplished a great deal in the two plus years of our development phase, and we are even more excited about the next expansion stage

So the next phase = A.I. & acquisition (see previous post)